Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by tickle1ston Nov 09, 2015 8:28pm

82 Views

Post# 24275308

RE:RE:RE:Hey JuniorTechieSluttieclownboypumper.

doonery...let me think about this for a minute..Times up...nope.

You will have noticed that my optimism has changed ..as in it has gone up a notch. But, caution is the key. And until this cr..ap gets their share printing press in order and they come up with something more than hopes for a deal, the real investors we need to make this fly are going to sit the dance out.

The new pig figures a couple of months... I'm hoping so.

Bullboard Posts

A potential breakthrough in spinal cord and optic nerve injury treatment